A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.
Times cited: 22
Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National Lymphocare Study.
Journal of Clinical Oncology.
Times cited: 63
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non-Hodgkin's lymphoma.
Clinical Cancer Research.
Times cited: 97